| Clear-cell carcinoma of the abdominal wall after cesarean delivery. | |
| | |
MedLine Citation:
|
PMID: 22825261 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: : Clear-cell carcinoma transformed from an abdominal wall scar is extremely rare; there are only 22 cases reported in literature. Here we report a case of a patient with clear-cell carcinoma of the abdominal wall after cesarean delivery and review the relevant literature. CASE: : A 49-year-old woman presented with a chief complaint of progressively growing mass of cesarean scar and periodic pain with menstruation for 25 years. Wide surgical resection with clear margins was performed. Clear-cell carcinoma was demonstrated by pathologic examination. The patient underwent six cycles of adjutant chemotherapy postoperatively. The patient remains clinically free of recurrence 8 months after treatment. CONCLUSION: : Comprehensive treatment consisting of radical surgery combined with adjuvant therapy should be considered for this uncommon condition. |
| | |
Authors:
|
Xiaoyan Li; Jiaxin Yang; Dongyan Cao; Jinghe Lang; Jie Chen; Keng Shen |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 120 ISSN: 1873-233X ISO Abbreviation: Obstet Gynecol Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-07-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 445-8 Citation Subset: AIM; IM |
Affiliation:
|
From the Departments of Obstetrics and Gynecology and Pathology, Chinese Academy of Medical Science, Peking Union Medical College Hospital, Beijing, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tattoo pigment lymphadenopathy mimicking metastasis in vulvar cancer.
Next Document: Hyperosmolar glucose injection for the treatment of heterotopic ovarian pregnancy.